The Department of the Army awarded a $324,493.13 Project Grant to Path, a global health nonprofit in Seattle, under the Pest Management and Vector Control Research program (CFDA 12.355). The grant supports the research and development of novel repellent textiles to protect deployed military personnel from disease vectors, such as mosquitoes, ticks, and flies. The 3-year project aims to further advance Anovoteks' technology for creating repellent fabrics for Army combat uniforms and components of...
This federal Project Grant award, valued at $310,124.67, was issued by the U.S. Department of the Army Medical Command to The Ohio State University under the Pest Management and Vector Control Research program (CFDA 12.355). The grant supports the development of novel, safe pesticides derived from the guayule plant for controlling medically relevant mosquitoes. The research aims to create advanced vector control interventions to protect deployed military personnel from arthropod-borne...
The Department of the Army's Medical Command awarded a $325,000.03 Project Grant to The Mentor Initiative, a UK-based non-profit organization, under the Pest Management and Vector Control Research program (CFDA 12.355). The grant supports research and development efforts to reduce filth fly populations and the transmission of diarrheal pathogens in harsh settings. The 3-year project, which began on December 20, 2024, aims to develop innovative interventions to protect military personnel and...
This $649,972 federal Project Grant award from the U.S. Department of Agriculture's National Institute of Food and Agriculture (NIFA) Small Business Innovation Research (SBIR) Program supports the development of textile coating systems that incorporate biobased insect repellents. The grantee, Insectapel LLC, is a for-profit limited liability company focused on creating innovative, environmentally-friendly alternatives to synthetic chemical insect repellents. The research aims to leverage...
The Department of the Army Medical Command awarded a $564,698.00 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Texas A&M Engineering Experiment Station (Tees) to develop "Engineered Therapeutic Extracellular Vesicles to Resolve Pyridostigmine Bromide-Induced Enteric Neuroinflammation in Gulf War Illness." The grant, with a performance period from November 1, 2024 to October 31, 2027, will support advanced biomedical research...
This Cooperative Agreement, awarded by the Defense Health Agency, provides $568,275 in funding to Conserv Bioscience LIMITED, a foreign-owned for-profit organization, to develop an mRNA multivalent approach including pre-erythrocytic-stage antigens and mosquito saliva antigens to broaden the immune targets against malaria infection. The funding is provided through the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical...
This $505,238 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to identify and characterize skin-associated compounds that can alter mosquito landing and feeding behavior. The overarching goal is to develop improved topical mosquito repellents by leveraging mosquitoes' olfactory and gustatory (taste) systems. The research will validate...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $211,038 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Johns Hopkins University to target a reductive dehalogenase enzyme as a new strategy for controlling mosquito populations. The research aims to investigate how this enzyme protects insects like fruit flies and mosquitoes from the accumulation of endogenous halotyrosines, which can suppress fertility. The project will examine the role...
Hbvtech received a $279,854 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support Hbvtech's research from May 2021 through April 2023 to develop a novel hepatitis B virus drug aimed at effectively curing chronic hepatitis B. The Military Medical Research and Development program seeks to transform military and public health through innovative medical research solutions,...
The U.S. Department of the Army Medical Command awarded a $542,247 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Fraunhofer USA, Inc. for the project "BORON-DOPED DIAMOND ELECTRODE ARRAYS FOR MALARIA DETECTION IN SALIVA AND URINE." The grant, with a performance period from March 1, 2025 to February 28, 2027, supports the development of boron-doped diamond electrode arrays for the detection of malaria in saliva and urine samples. Fraunhofer...